Atypical chronic myeloid leukemia, BCR-ABL1 negative

Clinical trials for Atypical chronic myeloid leukemia, BCR-ABL1 negative explained in plain language.

Never miss a new study

Get alerted when new Atypical chronic myeloid leukemia, BCR-ABL1 negative trials appear

Sign up with your email to follow new studies for Atypical chronic myeloid leukemia, BCR-ABL1 negative, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1 Completed 1

New drug cocktail shows promise for Hard-to-Treat leukemia

Disease control Ongoing

This early-phase trial tests a combination of three drugs—azacitidine, venetoclax, and pevonedistat—in adults newly diagnosed with a challenging form of acute myeloid leukemia (AML). The goal is to find the best dose and see if the combo can improve remission rates. About 40 part…

Matched conditions: ATYPICAL CHRONIC MYELOID LEUKEMIA, BCR-ABL1 NEGATIVE

Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC

Atypical chronic myeloid leukemia, BCR-ABL1 negative

Get alerted when new Atypical chronic myeloid leukemia, BCR-ABL1 negative trials appear

New drug cocktail shows promise for Hard-to-Treat leukemia